Roots Analysis provides market research and consulting in the pharmaceutical industry. Focused
on providing an informative and impartial view on key issues facing the industry, our research is
primarily driven by an in-depth analysis covering the following parameters:
■ Technology evolution
■ Research and development
■ Existing market landscape
■ Future Commercial potential
■ Regulatory concerns
■ Regional growth drivers
■ Risks and opportunities
We specialise in analysing areas which have lacked quality research so far or require more
focused understanding within the broader industry. All our reports are structured in a way to
enable the reader develop a thorough perspective on the given subject. Apart from writing reports
on identified areas, we also provide bespoke research / consulting services dedicated to serve our
clients in the best possible way.
Publications found:
136
Sort by:
ADC Contract Manufacturing Market (5th Edition) by Phase of Development (Phase I, Phase II and Phase III), Scale of Operation (Clinical and Commercial), Type of Component Manufacturing (Antibody Manufacturing, HPAPI / Cytotoxic Payload, Linker and Conjugation Manufacturing, and Fill / Finish), Target Indications (Solid Tumors, Hematological Malignancies and Others), Type of Payload (Maytansinoid, Auristatin, Camptothecin, PBD and Others), Type of Linker (SMCC, VC, Malemide, Peptide Linker and Others), Type of Antibody Origin (Humanized, Chimeric, Murine, Human and Others), Antibody Isotype (IgG1and Others) and Geography (North America, Europe, Asia-Pacific and Rest of the World), 2022-2035
US$ 4,799.00
The ADC contract manufacturing market is expected to reach USD 2.8 billion by 2022 anticipated to grow at a CAGR of 11.8% during the forecast period 2022-2035. Over the past two decades, antibody ther...
July 2022
464 pages
Gene Therapy Market by Type of Therapy, Type of Gene Delivery Method Used, Type of Vector Used, Target Therapeutic Areas, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts (5th Edition), 2022-2035
US$ 4,799.00
Gene Therapy Market (5th Edition) by Type of Therapy (Gene Augmentation, Oncolytic Viral Therapy, Immunotherapy and Others), Type of Gene Delivery Method Used (Ex vivo and In vivo), Type of Vector Use...
June 2022
865 pages
RNA Extraction and RNA Purification Market By Type of Product (Kits / Reagents and Instruments), Application Area(s) (Molecular Diagnostics, Drug Discovery & Development, Agriculture and Animal Research, and Other Application Area(s)), End Users (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Academics and Research Institutes, Others), and Key Geographical Regions (North America, Europe, Asia-Pacific, MENA, Latin America and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The RNA extraction and RNA purification kit market is currently estimated to be valued at $29.5 billion in 2022. Over the past few decades, the field of molecular biology has witnessed significant adv...
June 2022
322 pages
RNAi Therapeutics and Technology Market (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition) by Key Therapeutic Areas (Oncological Disorders, Genetic Disorders, Metabolic Disorders, Hematological Disorders, Ophthalmic Disorders and Other Disorders), Route of Administration (Subcutaneous, Intravenous, Topical and Intradermal), Leading Industry Players, Type of RNAi Molecule (siRNA and shRNA) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The projected value of RNAi therapeutics and technology market is expected to be valued at USD 1,200 million in 2022 and is anticipated to grow at a CAGR of 17% during the forecast period 2022-2035. R...
May 2022
421 pages
3D Cell Culture Market by Scaffold Format (Scaffold Based and Scaffold Free System), Products (Hydrogel / Extracellular Matrix (ECM), 3D Bioreactor, 3D Petri Dish, Hanging Drop Plate, Microfluidic System, Micropatterned Surface, Microcarrier, Solid Scaffold, and Suspension System), Application Areas (Cancer Research, Drug Discovery and Toxicology, Stem Cell Research, Tissue Engineering and Regenerative Medicine), Purpose (Research Use and Therapeutic Use), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts (4th Edition), 2022-2035
US$ 4,799.00
The 3D cell culture market is expected to reach USD 1.2 billion by 2022 anticipated to grow at a CAGR of 16.7% during the forecast period 2022-2035. For a long time, animal testing has been a primary...
April 2022
481 pages
Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized (Antibodies, Cell and Gene Therapies, Vaccines and Other Biologics), Type of Primary Packaging System (Vials, Syringes, Cartridges, Ampoules and Others) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The lyophilization services market is expected to reach USD 2.2 billion in 2022 anticipated to grow at a CAGR of 6.8% during the forecast period 2022-2035. Over the past decade, there has been a consi...
April 2022
225 pages
Coronary Drug Eluting Stent Market - Distribution by Type of Drug Eluted (Sirolimus, Paclitaxel, Everolimus, Zotarolimus and Others), Stent Material (Platinum Chromium, Cobalt Chromium, Stainless Steel and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The coronary drug eluting stent market is currently valued at $3.8 billion in 2022 and is anticipated to experience a compounded annual growth rate (CAGR) of 9.26% throughout the forecast period. Card...
April 2022
254 pages
Viral Vaccine Cell Culture Media Market Distribution by Type of Cell Culture (Adherent and Suspension), Type of Media (Animal Component Free, Protein Free and Serum Free), Scale of Operation (Clinical Operations and Commercial Operations), Type of End-User (Industry Players and Non-Industry Players), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The viral vaccine cell culture market is expected to reach USD 1.6 billion in 2022 anticipated to grow at a CAGR of 5.8% during the forecast period 2022-2035. In recent years, there has been a signifi...
March 2022
180 pages
Live Biotherapeutic Products and Microbiome Manufacturing Market by Type of Product Manufactured (API and FDF), Type of Formulation (Solids, Oral Liquids and Injectables), Type of Primary Packaging Used (Blister Packs, Glass / Plastic Bottles, Pouches / Sachets and Vials), Scale of Operation (Clinical and Commercial), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022 – 2035
US$ 4,799.00
The projected value of microbiome manufacturing market is expected to be valued at USD 23 million in 2022 and is anticipated to grow at a CAGR of 20% during the forecast period 2022-2035. In light of...
February 2022
305 pages
Oral Proteins and Oral Peptides Market (4th Edition) by Target Disease Indication (acromegaly, celiac disease, chronic idiopathic constipation, enteric hyperoxaluria, inflammatory bowel disease and type II diabetes), Type of Molecule (protein and peptide), Technology Platforms, Biological Target (GC-C, insulin receptor, oxalate and others), Mechanism of Action (receptor stimulation, substrate degradation and others), Key Players, and Key Geographical Regions (North America, Europe, Asia-Pacific and RoW), 2022-2032
US$ 4,799.00
The oral protein and oral peptide market is expected to reach USD 1.4 billion in 2022 anticipated to grow at a CAGR of 20% during the forecast period 2022-2032 Since the introduction of the initial pr...
February 2022
481 pages
Complement Inhibitors Market: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The projected value of complement inhibitors market is expected to be valued at USD 6,800 million in 2022 and is anticipated to grow at a CAGR of 15% during the forecast period 2022-2035. Since the ap...
February 2022
131 pages
Cell and Gene Therapy CRO Market (3rd Edition): Distribution by Area of Expertise (Cell Therapy and Gene Therapy), Scale of Operation (Clinical, Preclinical and Discovery), Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Autoimmune Disorders, Blood Disorders, Rare / Genetic Disorders, Ophthalmological Disorders, and Other disorders), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The cell and gene therapy CRO market is currently valued at $713 million in 2022 and is projected to grow at a compounded annual growth rate (CAGR) of 18% during the forecast period. Cell and gene the...
January 2022
330 pages
Site Management Organization Market – Distribution by Therapeutic Areas (Oncological Disorders, CNS Disorders, Infectious Diseases, Cardiovascular Diseases and Others), Trial Phases (Phase I, Phase II, Phase III and Phase IV), Clinical Trial Components (Site Management, Onsite Monitoring, Project Management and Others), Type of Interventions (Therapeutics, Devices and Surgical Procedure) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and RoW): Industry Trends and Global Forecasts, 2021-2035
US$ 4,799.00
The site management organization market is expected to reach USD 8.5 million by 2021 anticipated to grow at a CAGR of 10% during the forecast period 2021-2035 Clinical trials constitute a pivotal elem...
October 2021
270 pages
Anti CD47 Drugs Market by Target Disease Indication (Acute Myeloid Leukemias, Non-Hodgkin Lymphoma, Colorectal Cancers, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral Muscositis, Small Cell Lung Cancers), Type of Molecule (Biologics and Small Molecule) Key Players and Key Geographical Regions (US, France, Germany, Italy, Spain, UK, Australia, China, India and Israel): Industry Trends and Global Forecasts, 2021-2035
US$ 4,799.00
The anti CD47 market is expected to reach USD 0.1 billion in 2023 and anticipated to grow at a CAGR of 42.9% during the forecast period 2021-2035. According to the World Health Organization (WHO), can...
October 2021
178 pages
Treg Therapy Market by Target Indications (Crohn Disease, Bipolar Disorder, Allergic Rhinoconjunctivitis, COVID 19, Diabetes Mellitus, Systemic Lupus Erythematosus, Alzheimer Disease and Graft Vs Host Disease), Key Players and Key Geographies (North America, Europe and Asia Pacific): Industry Trends and Global Forecast, 2021-2035
US$ 4,799.00
The Treg therapy market is expected to reach USD 5 million in 2023 and anticipated to grow at a CAGR of 44% during the forecast period 2023-2035. The application of regulatory T cell (Treg) therapies...
October 2021
145 pages
Biospecimen Procurement Market by Therapeutic Area (Oncological Disorders and Other Disorders), Type of Biospecimen for Oncological Studies (FFPE Tissue, Frozen Tissue, Plasma / Serum and Other Biospecimens), Type of Biospecimen for Non-Oncological Studies (Blood Products, Human Tissue and Other Biospecimens), Key Geographical Regions (North America (US and Canada), Europe (Germany, France, Italy, UK, Spain and Other European Countries) and Asia Pacific (China, India, Japan and other Asia-Countries and Rest of the World)): Industry Trends and Global Forecasts, 2021-2030
US$ 4,799.00
The biospecimen procurement market is expected to reach USD 52 million in 2021 and anticipated to grow at a CAGR of 16% during the forecast period 2021-2035. Biomedical research follows a cyclical pat...
August 2021
159 pages
Cell Therapy Packaging Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging), Scale of Operation (Clinical and Commercial) and Geography (North America, Europe, Asia Pacific and Rest of the World) , 2021-2030
US$ 4,799.00
The cell therapy packaging market is expected to reach USD 221 million in 2021 and anticipated to grow at a CAGR of 19% during the forecast period 2021-2030. Advanced therapy medicinal products, encom...
June 2021
180 pages
Lipid CMO Market by Type of Lipid (Liposomes / Lipid Nanoparticles, Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids and Others), Company Size (Small, Mid-Sized and Large / Very Large), Scale Of Operation (Preclinical, Clinical and Commercial) and Key Geographical Regions (North America, Europe, Asia Pacific, MENA and Latin America and Rest Of The World): Industry Trends and Global Forecasts, 2021-2030
US$ 4,799.00
The lipid CMO market is expected to reach USD 2.4 billion in 2021 and anticipated to grow at a CAGR of 10.8% during the forecast period 2021-2030. Approximately 90% of existing drug candidates in deve...
June 2021
230 pages
Vascular Disrupting Agents Market, 2021-2030: Distribution by Target Indications (Chemotherapy-Induced Neutropenia, Glioblastoma, Hepatocellular Carcinoma, Malignant Pleural Mesothelioma, Non-Small Cell Lung Cancer, Prostate Cancer, Recurrent Platinum Resistant Ovarian Cancer, Transitional Cell Cancer of Renal Pelvis and Ureter), Therapeutic Area (Hematological Malignancies, Solid Tumors and Other Therapeutic Areas), Type of Molecule (Small Molecule (Tubulin Binding Agents and Flavonoids) and Ligand-Directed Agents) and Ligand-Directed Agents), Type of Therapy (Monotherapy, Combination Therapy And Both), Route of Administration (Oral, Intravenous), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World)
US$ 4,799.00
The vascular disrupting agents market is expected to reach USD 23 million in 2021 and anticipated to grow at a CAGR of 65% during the forecast period 2021-2030. Solid tumors constitute roughly 90% of...
April 2021
295 pages
Non Hormonal Contraceptives Market for Women’s Health by Target Indication (Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis and Others), Type of Molecule (Biologic and Small Molecule), Purpose of Therapy (Treatment of Disease and Management of Symptoms), Mechanism of Action (Antagonist, Agonist, Inhibitor and Modulator), Route of Administration (intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal and others), and Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2021-2030
US$ 4,799.00
The non hormonal contraceptives market is expected to reach USD 1.8 billion in 2021 and anticipated to grow at a CAGR of 22% during the forecast period 2021-2030. According to the World Health Organiz...
March 2021
225 pages
Pharmaceutical Polymers / Medical Polymers Market - Distribution by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Others), Area of Application (Medical Devices, Excipients, Packaging and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global pharmaceutical polymer / medical polymers market is expected to reach USD 20 billion in 2023 anticipated to grow at a CAGR of 7.3% during the forecast period 2023-2035. Polymers, composed o...
January 2021
205 pages
Medical Device Coating Market: Distribution by Type of Medical Device (Class I, Class II, Class III), Type of Coating Material (Metal Coatings, Polymer Coatings, and Other Coatings), Company Size (Very Small, Small, Mid-sized, and Very Large), and Key Geographies (North America, Europe, Asia and Rest of the World) – Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The medical device coating market is expected to reach USD 7.7 billion in 2023 anticipated to grow at a CAGR of 7.7% during the forecast period 2023-2035. The World Health Organization (WHO) reports a...
January 2021
213 pages
Neoantigen Targeted Therapies Market Target Indications (Bone And Cartilage Cancer, Colorectal Cancer, Head And Neck Cancer, Renal Carcinoma, Hepatocellular Carcinoma, Lung Cancer, Gynecological Cancer And Others), Type Of Treatment (Personalized And Off-The-Shelf), Type Of Immunotherapy (Dendritic Cell Vaccine, DNA / RNA-Based Vaccine, Protein / Peptide-Based Vaccine And TIL-Based Therapy), Route Of Administration (Intradermal, Intravenous, Subcutaneous, And Others) And Key Geographical Regions (US, UK, Germany, France, Italy, Spain And Rest Of The World), 2019-2030
US$ 4,799.00
The global neoantigen targeted market is expected to reach USD 3 million by 2030 and anticipated to grow at a CAGR of 55% during the forecast period 2019-2030 Cancer poses a substantial global health...
May 2019
323 pages
